CMV

FDA approves Merck's letermovir to prevent CMV in kidney transplant recipients
Healio
Tue, 06/6/23 - 04:16 pm
Merck
FDA
letermovir
CMV
kidney transplants
Prevymis
Where Will Moderna Be in 1 Year?
Motley Fool
Thu, 04/20/23 - 10:44 am
Moderna Therapeutics
MRNA
vaccines
COVID-19
RSV
CMV
Hookipa halts spending on cytomegalovirus vaccine after seeing phase 2 data
Fierce Biotech
Wed, 03/15/23 - 09:21 pm
Hookipa
CMV
vaccines
HB-101
kidney transplants
Merck seeks more approvals for infectious disease drug
Endpoints
Fri, 02/17/23 - 11:26 am
Merck
CMV
FDA
Prevymis
Merck tees up Prevymis filing in kidney transplant recipients after phase 3 trial win
Fierce Pharma
Mon, 10/24/22 - 10:56 am
Merck
Prevymis
kidney transplants
clinical trials
CMV
IDWeek
FDA offers support for Takeda's potential cytomegalovirus drug ahead of adcomm
Endpoints
Wed, 10/6/21 - 11:17 pm
Takeda
FDA
CMV
post-transplant cytomegalovirus
Shire
maribavir
FDA Accepts NDA for Takeda’s Maribavir
BioSpace
Sun, 05/23/21 - 02:56 pm
Takeda
post-transplant cytomegalovirus
CMV
maribavir
FDA
Takeda tees up priority review for storied CMV drug from its $62B Shire buyout
Endpoints
Fri, 05/21/21 - 10:51 am
Shire
Takeda
M&A
CMV
maribavir
Here Are the Most Exciting Vaccines in Moderna's Pipeline
Motley Fool
Sun, 03/14/21 - 10:47 pm
Moderna Therapeutics
vaccines
cancer vaccines
COVID-19
CMV
Takeda's maribavir clears cytomegalovirus infections in phase 3
Fierce Biotech
Fri, 02/12/21 - 11:02 am
Takeda
clinical trials
maribavir
CMV
Meet Moderna's Most Likely Blockbusters After Its COVID Vaccine
Motley Fool
Sat, 12/26/20 - 08:13 pm
Moderna Therapeutics
CMV
cytomegalovirus
mRNA-1647
Takeda's maribavir hits phase 3 goal as pharma looks forward to regulatory talks
Fierce Biotech
Fri, 12/4/20 - 11:00 am
Takeda
TAK-620
clinical trials
CMV
Moderna, though early in development, prepares its vaccine for market
BioPharma Dive
Fri, 01/10/20 - 10:25 am
Moderna Therapeutics
CMV
vaccines
Astellas, Vical's CMV vaccine comes up short in Phase 3
Biopharma Dive
Tue, 01/23/18 - 02:49 pm
Astellas
Vical
CMV
cytomegalovirus
vaccines
clinical trials
ASP0113
Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris
Endpoints
Thu, 11/9/17 - 10:06 am
Merck
FDA
CMV
Prevymis
AiCuris
Merck tees up US/European applications for letermovir after detailing PhIII antiviral success
Endpoints
Sun, 02/26/17 - 12:50 pm
Merck
Europe
letermovir
clinical trials
CMV
VBI Vaccines Begins Enrolling Patients in a Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate
Yahoo
Thu, 06/23/16 - 09:08 am
VBI Vaccines
clinical trials
vaccines
CMV
cytomegalovirus
Chimerix scraps two PhIII trials as it regroups in wake of a setback
Fierce Biotech
Mon, 02/22/16 - 10:09 am
Chimerix
clinical trials
Brincidofovir
CMV
antivirals
Merck, AiCuris announce publication of letermovir Phase 2 trial results
The Fly on the Wall
Thu, 05/8/14 - 11:18 am
AiCuris
Merck
letermovir
CMV
Astellas/Vical Start TransVax Phase III Study
Yahoo/Zacks
Fri, 06/28/13 - 10:30 am
CMV
cytomegalovirus
TransVax
clinical trials
Astellas
vaccines
Vical

Pages